Chapters in books:
1. Shalev AY, Schreiber S, Galai T, Early Psychiatric Intervention in Hospitalized Survivors of Traumatic Injury: The Case of the "405" Tel-Aviv Jerusalem Bus. In Lundeberg JE, Otto U & Rybeck B (eds.) Wartime Medical services, Stockholm, FOA, pp. 183-188, 1990.
2. Schreiber S, Lerer B, "Failure to thrive" in Depressed, Elderly Patients: a New Concept or a Different Name for Depression? In: P. Hofmann, G. Wieselmann & H.G. Zapotoczky (Eds.), International Conference on Aging, Depression and Dementia, Verlag Wilhelm Maudrich, Wien, pp. 229-232, 1995.
3. Schreiber S, Stein D, Floman Y, Psychologic approaches to the management and treatment of chronic low back pain. In: JN Weinstein & SW Wiesel (eds.) The Lumbar Spine, WB Saunders Company, Philadelphia, pp. 1018-1041, 1996.
4. Bleich A, Kutz I, Klein E, Rubinstein Z, Schreiber S, Early intervention with adults following traumatic stress events. In: E Somer & A Bleich (eds.) Mental Health in Terror’s Shadow: The Israeli Experience, Ramot – Tel Aviv University Press, Tel Aviv, pp. 335-394, 2005.
Peer-Reviewed Journal Articles:
1. Shalev, A.Y., Orr, S.P., Peri, T., Schreiber S., Pitman, R.K., Physiologic Responses to Loud Tones in Israeli Patients With Posttraumatic Stress Disorder. Arch Gen Psychiatry, 49: 870-875 (1992).
2. Schreiber, S., Shalev, A.Y., Lithium Augmentation for Mianserin Resistant Depression in the Elderly. Harefuah (Hebrew), 123: 250-251 (1992).
3. Shalev, A.Y., Schreiber, S., Galai, T., Melmed RN, Post-Traumatic Stress Disorder following medical events. Brit J Clin Psychology, 32: 247-253 (1993).
4. Schreiber, S., Diazepam induced disinhibition. Harefuah (Hebrew), 124: 681-682 (1993).
5. Schreiber, S., Benzodiazepines - an update. Harefuah, (Hebrew), 125: 172-174 (1993).
6. Schreiber, S., Galai-Gat, T., Uncontrolled pain following physical injury as the core-trauma in post-traumatic stress disorder. Pain, 54: 107-110 (1993).
7. Shalev, A.Y., Schreiber, S., Galai, T., Early Psychological Responses to Traumatic Injury. Journal of Traumatic Stress, 6: 441-450 (1993).
8. Schreiber, S., Migration, traumatic bereavement and transcultural aspects of psychological healing: a case report of loss and grief of a refugee from the Begameder county in Ethiopia. Brit J Med Psychology, 68:135-142 (1995).
9. Schreiber, S., Pick, C.G., Fluoxetine for blepharospasm: interaction of serotonin and dopamine. J Nerv Ment Dis, 18:719-721 (1995).
10. Schreiber, S., Backer, M.M., Pick, C.G., The opioid properties of a tetracyclic antidepressant. Analgesia, 1: 707-710 (1995).
11. Shalev, A.Y., Caneti, L., Peri, T., Schreiber, S., Predictors of PTSD in Injured Trauma Survivors: A Prospective Study. Am J Psychiatry, 153: 219-225 (1996).
12. Schreiber, S., Backer, M.M., Yanai, J., Pick, C.G., The antinociceptive effect of fluvoxamine. Eur Neuropsychopharmacol, 6: 281-284 (1996).
13. Schreiber, S., Backer, M.M., Weizman, R., Pick, C.G., The antinociceptive effects of fluoxetine. The Pain Clinic, 9: 349-356 (1996).
14. Pick, C.G., Peter, Y., Schreiber, S., Weizman, R., Pharmacological characterization of buprenorphine, a mixed agonist-antagonist with kappa3 analgesia. Brain Research, 744: 41-46 (1997).
15. Schreiber, S., Lerer, B., Failure to thrive in elderly, depressed patients: a new concept or a different name for an old problem? Isr J Psychiatry Relat Sci, 34: 108-114 (1997).
16. Schreiber, S., Segman, R.H., Risperidone Induced Galactorrhea. Psychopharmacology, 130: 300-301 (1997).
17. Schreiber, S., Pick, C.G., Paroxetine for secondary stuttering: further interaction of serotonin and dopamine. J Nerv Ment Dis, 187: 465-467 (1997).
18. Pick, C.G., Peter, Y., Schreiber, S., Gavish, M., Weizman, R., Effect of the pregnane-related GABA-active steroid alphaxolone on mice performance in the staircase test. Brain Research, 765: 129-134 (1997).
19. Backer, M.M., Schreiber, S., Pick, C.G., Interaction between antidepressants and morphine alter gastrointestinal transit. Life Sciences, 61: PL109-PL113 (1997).
20. Schreiber, S., Backer, M.M., Weizman, R., Pick, C.G., Augmentation of opioids analgesia by the atypical antipsychotic drug risperidone in mice. Neuroscience Letters, 228: 25-28 (1997).
21. Weizman, A., Pankova, I.A., Schreiber, S., Pick, C.G., Flunarizine analgesia is mediated by mu opioid receptor. Physiology & Behavior 62: 1193- 1195 (1997).
22. Schreiber, S., Backer, M.M., Kaufman, J., Rigai, T., Pick, C.G., Interaction between the tetracyclic antidepressant Mianserin HCl and opioid receptors. Eur Neuropsychopharmacol, 8: 297-302 (1998).
23. Schreiber, S., Getslev, V., Weizman, A., Pick, C.G., The antinociceptive effect of moclobemide in mice is mediated by noradrenergic pathways. Neuroscience Letters, 253: 183-186 (1998).
24. Schreiber, S., Klag, E., Gross, Y., Segman, R.H., Pick, C.G., Beneficial effect of risperidone on sleep disturbance and psychosis following traumatic brain injury. International Clinical Psychopharmacology, 13: 273-275 (1998).
25. Weizman, R., Getslev, V., Pankova, I.A., Schreiber, S., Pick, C.G., Pharmacological interaction of the calcium channel blockers verapamil and flunarizine with the opioid system. Brain Research, 818: 187-195 (1999).
26. Amiaz, R., Stein, O., Dannon, P.N., Grunhaus, L., Schreiber, S., Resolution of treatment-refractory depression with naltrexone augmentation of paroxetine – a case report. Psychopharmacology, 143: 433-434 (1999).
27. Schreiber, S., Getslev, V., Weizman, R., Pick, C.G., The atypical neuroleptics clozapine and olanzapine differ regarding their antinociceptive mechanisms and potency. Pharm Biochem Behav, 64: 75-80 (1999).
28. Schreiber, S., Backer, M.M., Pick, C.G., The antinociceptive effect of venlafaxine in mice is mediated through opioid and adrenergic mechanisms. Neuroscience Letters, 273: 85-88 (1999).
29. Stern, L., Dannon, P.N., Hirshmann, S., Schreiber, S., Amital, D., Dolberg, O.T., Grunhaus, L., Aminophylline increases seizure length during electroconvulsive therapy. J ECT, 15: 252-257 (1999).
30. Grunhaus, L., Dannon, P.N., Schreiber, S., Dolberg, O.T., Amiaz, R., Ziv, R., Lepkifker, E., Repetitive Transcranial Magnetic Stimulation is as effective as ECT in the treatment of non-delusional major depressive disorder: an open study. Biol Psychiatry, 47: 314-324 (2000).
31. Vakil, E., Grunhaus, L., Nagar, I., Ben-Chaim, E., Dolberg, O.T., Dannon, P.N., Schreiber, S., The effect of electroconvulsive therapy (ECT) on implicit memory: skill learning and perceptual priming in patients with major depression. Neuropsychologia, 38: 1405-1414 (2000).
32. Schreiber, S., Backer, M.M., Herman, I., Shamir, D., Boniel, T., Pick, C.G., The antinociceptive effect of trazodone in mice is mediated through both m-opioid and serotonergic mechanisms. Behav. Brain Research, 114: 51-56 (2000).
33. Schreiber, S., Kampf-Scherf, O., Gorfine, M., Kelly, D., Oppenheim, Y., Lerer, B., Plant source derived phosphatidylserine for treatment of age-related cognitive impairment. Isr J Psychiatry Relat Sci, 37: 302-307 (2000).
34. Dannon, P.N., Schreiber, S., Dolberg, O.T., Shemer, L., Grunhaus, L., Transcranial Magnetic Stimulation is effective in the treatment of relapse of major depressive disorder. In J Psych Clin Pract, 4: 223-226 (2000).
35. Dolberg, O.T., Schreiber, S., Grunhaus, L., Transcranial Magnetic Stimulation induced switch into mania – a report of two cases. Biol Psychiatry, 49: 468-470 (2001).
36. Benjamin, J., Ben-Zion, I.Z., Dannon, P.N., Schreiber, S., Meiri, G., Ofek, A., Palatnik, A., Lack of association between joint hyperlaxity and panic disorder, and between joint hyperlaxity and sensitivity to carbon dioxide in healthy volunteers. Human Psychopharmacology, 16: 189-192 (2001).
37. Grunhaus, L., Hirschman, S., Dolberg, O.T., Schreiber, S., Dannon, P.N., Coadministration of melatonin and fluoxetine does not improve the 3-month outcome following ECT. J ECT, 17: 124-128 (2001).
38. Schreiber, S., Vinokur, S., Shavelzon, V., Pick, C.G., Shir, Y., The use of fluoxetine for chronic pain management: a six weeks comparison study with amitriptyline. Isr J Psychiatry Relat Sci, 38; 88-94 (2001).
39. Amiaz, R., Stein, O., Schreiber, S., Dannon, P.N., Dolberg, O.T., Grunhaus, L., Magnetic and seizure thresholds before and after six electroconvulsive treatments. J ECT, 17: 195-197 (2001).
40. Schreiber, S., Bleich, A., Pick, C.G., Venlafaxine and mirtazapine: Different mechanisms of antidepressant action, common opioid-mediated antinociceptive effects - a possible opioid involvement in severe depression? Journal of Molecular Neuroscience, 18: 143-149 (2002).
41. Dannon, P.N., Dolberg, O.T., Schreiber, S., Grunhaus, L., Three and six-month outcome following courses of either ECT or rTMS in a population of severely depressed individuals – preliminary report. Biol Psychiatry, 51: 687-690 (2002). http://dx.doi.org/10.1016/S0006-3223(01)01274-4
42. Dolberg, O.T., Klag, E., Gross, Y., Schreiber, S., Relief of SSRI Induced Sexual Dysfunction with Low-Dose Mianserin in Patients with Traumatic Brain Injury. Psychopharmacology, 161: 404-407 (2002). http://dx.doi.org/10.1007/s00213-002-1097-z
43. Dolberg, O.T., Dannon, P.N., Schreiber, S., Grunhaus, L., Magnetic motor threshold and response to TMS in major depressive disorder. Acta Psychiatrica Scandinavica, 106: 220-223 (2002). http://dx.doi.org/10.1034/j.1600-0447.2002.01334.x
44. Grunhaus, L., Schreiber, S., Dolberg, O.T., Hirshman, S., Dannon, P.N., Response to ECT in major depression: are there differences between unipolar and bipolar depression? Bipolar Disorders, 4 (Suppl 1): 91-93 (2002). http://dx.doi.org/10.1034/j.1399-5618.4.s1.40.x
45. Dolberg, O.T., Dannon, P.N., Schreiber, S., Grunhaus, L., Transcranial magnetic stimulation in patients with bipolar depression: a double blind controlled study. Bipolar Disorders, 4 (Suppl 1): 94-95 (2002). http://dx.doi.org/10.1034/j.1399-5618.4.s1.41.x
46. Schreiber, S., Rigai, T., Katz, Y., Pick, C.G., The antinociceptive effect of mirtazapine in mice is mediated through serotonergic, noradrenergic and opioid mechanisms. Brain Research Buletin, 58: 599-603 (2002). http://dx.doi.org/10.1016/S0361-9230(02)00825-0
47. Schreiber, S., Dannon, P.N., Goshen, E., Amiaz, R., Zwas, T.S., Grunhaus, L., Right pre-frontal rTMS treatment for refractory auditory command hallucinations - a neuroSPECT assisted case-study. Psychiatric research: Neuroimaging, 116: 113-117 (2002). http://dx.doi.org/10.1016/S0925-4927(02)00065-3
48. Grunhaus, L., Schreiber, S., Dolberg, O.T., Polak, D., Dannon, P.N., A randomized controlled comparison of ECT and rTMS in severe and resistant non-psychotic major depression. Biological Psychiatry, 53: 324-331 (2003). http://dx.doi.org/10.1016/S0006-3223(02)01499-3
49. Schreiber, S., Backer, M.M., herman, I., Shamir, D., Rigai, T., Bar-Hamburger, R., Pick, C.G., Mianserin and Trazodone Significantly Attenuate the Intensity of Opioid Withdrawal Symptoms in Mice. Addiction Biology, 8: 107-114 (2003). http://dx.doi.org/10.1080/1355621031000069954
50. Zohar, O., Schreiber, S., Getslev, V., Schwartz, J.P., Mullins, P.G., Pick, C.G., Closed-head minimal traumatic brain injury produces long term cognitive deficits in mice. Neuroscience, 118; 949-955 (2003). http://dx.doi.org/10.1016/S0306-4522(03)00048-4
51. Schreiber, S., Shmueli, D., Grunhaus, L., Dolberg, O.T., Feldinger, E., Magora, F., Shapira, S.C., The influence of electroconvulsive therapy (ECT) on pain threshold and pain tolerance in major depression patients before, during and after treatment. Eur J Pain, 7; 419-424 (2003). http://dx.doi.org/10.1016/S1090-3801(02)00146-5
52. Weizman, T., Pick, C.G., Backer, M.M., Rigai, T., Bloch, M., Schreiber, S., The antinociceptive effect of amisulpride in mice is mediated through opioid mechanisms. Eur J Pharmacol, 478; 155-159 (2003). http://dx.doi.org/10.1016/j.ejphar.2003.08.049
53. Schreiber, S., Yoeli, N., Paz, G., Barbash, G.I., Varssano, D., Fertel, N., Hassner, A., Drory M, Halperin P, Hospital preparedness for possible non-conventional casualties: Beyond procedures and protocols. General Hospital Psychiatry, 26; 359-366 (2004). http://dx.doi.org/10.1016/j.genhosppsych.2004.05.003
54. Schreiber, S., Soskolne, V., Kozohovitch, H., Deviri, E., Holocaust survivors coping with open-heart surgery decades later: post-traumatic symptomatology and quality of life. General Hospital Psychiatry, 26; 443-452 (2004). http://dx.doi.org/10.1016/j.genhosppsych.2004.06.005
55. Feldinger, E., Kaminsky, I., Bloch, M., Schreiber, S., Psychiatric examination performed by phone for determining guardianship. Does it have a legal validity? Harefuah, 143; 710-712 (2004).
56. Peles, E., Schreiber, S., Gordon, J., Adelson, M., Significantly higher methadone dose for methadone maintenance treatment (MMT) patients with chronic pain. PAIN, 113: 340-346 (2005). http://dx.doi.org/10.1016/j.pain.2004.11.011
57. Barkai, G., Goshen, E., Zwas, T.S., Dolberg, O.T., Pick, C.G., Bonne, O., Schreiber, S., Acetazolamide enhanced neuroSPECT scan revealing mTBI induced functional impairment not otherwise discernible. Psychiatric Research - Neuroimaging, 132: 279-283 (2005). http://dx.doi.org/10.1016/j.pscychresns.2004.09.00
58. Soskolne, V., Kozohovitch, H., Deviri, E., Schreiber, S., Past history of prolonged traumatization and present health-related Quality-of-life: Holocaust survivors before and after open-heart surgery. Stress and Health, 21: 61-72 (2005).
http://dx.doi.org/10.1002/smi.1040
59. Herman, I., Shamir, D., Bar-Hamburger, R., Pick, C.G., Schreiber, S., The effect of mianserin add-on, on the intensity of opioid withdrawal symptoms during detoxification program - a randomized, double blind, placebo controlled, prospective study. Addictive Behaviors, 30: 1154-1167(2005). http://dx.doi.org/10.1016/j.addbeh.2004.12.004
60. Pick CG, Chernes Y, Rigai T, Rice KC, Bloch M, Schreiber S, The antinociceptive effect of zolpidem and zopiclone in mice. Pharmacology, Biochemistry and Behavior, 81: 417-423 (2005). http://dx.doi.org/10.1016/j.pbb.2005.02.013
61. Dolberg, O.T., Barkai, G., Gross, Y., Schreiber, S., Differential effects of topiramate in patients with traumatic brain injury and obesity – a case series. Psychopharmacology, 179: 838-845 (2005). http://dx.doi.org/10.1007/s00213-004-2117-y
62. Peles, E., Schreiber, S., Adelson, M., Variables associated with perceived sleep disorders in methadone maintenance treatment (MMT) patients. Drug and Alcohol Dependence, 82: 103-110 (2006). http://dx.doi.org/10.1016/j.drugalcdep.2005.08.011
63. Zohar, O., Getslev, V., Schreiber, S., Pick, C.G., Morphine Protects for Head Trauma Induced Cognitive Deficits in Mice. Neuroscience letters, 394: 239-242 (2006). http://dx.doi.org/10.1016/j.neulet.2005.10.099
64. Peles, E., Schreiber, S., Adelson, M., Factors predicting retention in treatment: 10 year experience of a methadone maintenance treatment (MMT) clinic in Israel. Drug and Alcohol Dependence, 82: 211-217 (2006). http://dx.doi.org/10.1016/j.drugalcdep.2005.09.004
65. Schreiber, S., Pick, C.G., From selective to highly-selective SSRIs: A comparison of the antinociceptive properties of fluoxetine, fluvoxamine, citalopram and escitalopram, Eur Neuropsychopharmacol, (in press). http://dx.doi.org/10.1016/j.euroneuro.2005.11.013
|
